CRISPR Cure For Sickle Cell May Be Slowed By Black Patients' Mistrust

The video discusses Maya Washington's life with sickle cell disease, highlighting its challenges and the lack of visible symptoms. It covers the genetic nature of the disease, its impact on health, and the current treatment options, including bone marrow transplants and emerging CRISPR gene editing. The video also addresses the mistrust in the medical community among black patients, which affects clinical trial participation, and the efforts to build trust through community outreach.

What is the primary demographic affected by sickle cell disease in the United States?

• African Americans

• Caucasian Americans

• Asian Americans

• Hispanic Americans

What is the only current option to cure sickle cell disease?

• Radiation therapy

• Chemotherapy

• Bone marrow transplant

• Gene therapy

How does CRISPR aim to treat sickle cell disease?

• By reducing the symptoms of the disease

• By increasing the production of red blood cells

• By editing the DNA of stem cells

• By replacing sickle-shaped cells with healthy ones

What is a significant barrier to black patient enrollment in clinical trials?

• Lack of awareness

• Mistrust of the medical community

• Geographical limitations

• High cost of participation

Which unethical medical practice is mentioned as a reason for mistrust among black patients?

• The Stanford Prison Experiment

• The Willowbrook Study

• The Milgram Experiment

• The Tuskegee Experiment

What organizations are involved in community outreach to build trust with black sickle cell patients?

• Centers for Disease Control and Prevention

• World Health Organization

• American Society of Hematology and Minority Coalition for Precision Medicine

• National Institutes of Health

What is Maya Washington's hope for the future regarding her condition?

• To move to a different country for treatment

• To see a permanent cure or medication

• To find a temporary relief

• To participate in more clinical trials